Histories of drug exposure of the NHL matched control groups.

<p>NSAID, non-steroidal anti-inflammatory drug; ACEI, angiotensin-converting enzyme inhibitor; COX-2, cyclooxygenase-2</p><p>Histories of drug exposure of the NHL matched control groups.</p

Demographic characteristics of the NHL group and the matched control group.

<p>*72 subjects, including 4 in the NHL group and 68 in the control group, were not stratified. HBV, hepatitis B virus; HCV, hepatitis C virus; DM, diabetes mellitus; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus</p><p>Demographic characteristics of the NHL group and the matched control group.</p

Crude and adjusted odds-ratios of non-Hodgkin lymphoma (NHL) associated with previous statin administration during the follow-up period in the study cohort.

<p>OR, odds ratio; CI, confidence interval; cDDD, cumulative defined daily dose.</p><p>*Adjusted for age, gender, urbanization level, HBV infection, HCV infection, autoimmune diseases (RA, SLE and sicca syndrome), diabetes mellitus, hypertension, hyperlipidemia, and the uses of ACEI, NSAID, COX-2 inhibitors and aspirin, fibrate and other lipid-lowering drugs.</p><p>Crude and adjusted odds-ratios of non-Hodgkin lymphoma (NHL) associated with previous statin administration during the follow-up period in the study cohort.</p